Clinical trial Recruiting at 1 site Observational Ages 18 to 99

Analyzing non-invasive methods for liver lesions in cirrhosis patients

Official title: Non-Invasive Characterization of Focal Liver Lesions in Liver Cirrhosis

Run by University Hospital, Bonn · NCT03746210 · Data updated 2026-11-12

This study is testing new non-invasive imaging methods to see if they can accurately identify liver lesions in patients with cirrhosis and predict their treatment outcomes and survival.

Quick facts

Study typeObservational
Ages18 Years to 99 Years
SexAll
Enrollment200 (estimated)
SponsorUniversity Hospital, Bonn
Academic / other
Locations1 site (Bonn)
StatusRecruiting
StartedJanuary 1, 2016
Main results expectedDecember 31, 2025
Study endsDecember 31, 2027
Registry record updatedMay 18, 2022
Trial IDNCT03746210 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults with liver cirrhosis who have focal liver lesions.

Probably not a fit

Patients who do not consent to participate or are under 18 years old will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on the non-invasive characterization of focal liver lesions in patients diagnosed with liver cirrhosis. It employs multiparametric ultrasound imaging and evaluates sarcopenia parameters to assess the diagnostic accuracy and predictive value of these non-invasive methods. The primary endpoint involves comparing the results to established gold standards such as CT, MRI, or histology, while the secondary endpoint examines the predictive value concerning mortality and treatment response. All procedures follow standard care protocols.

Why it matters

Potential benefit: If successful, this study could enhance the diagnostic accuracy for liver lesions, leading to better patient management and outcomes.

How similar studies have gone: Other studies have shown promise in using non-invasive methods for liver diagnostics, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* all patients with focal liver lesions and liver cirrhosis

Exclusion Criteria:

* no consent
* under 18 years

Where it's running

  • University Hospital Bonn
    Bonn, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.